Entity Details

Primary name ARRS_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP10523
EntryNameARRS_HUMAN
FullNameS-arrestin
TaxID9606
Evidenceevidence at protein level
Length405
SequenceStatuscomplete
DateCreated1989-07-01
DateModified2021-06-02

Ontological Relatives

GenesSAG

GO terms

Show/Hide Table
GOName
GO:0001664 G protein-coupled receptor binding
GO:0001750 photoreceptor outer segment
GO:0001917 photoreceptor inner segment
GO:0002031 G protein-coupled receptor internalization
GO:0002046 opsin binding
GO:0004864 protein phosphatase inhibitor activity
GO:0005829 cytosol
GO:0007166 cell surface receptor signaling pathway
GO:0016020 membrane
GO:0016056 rhodopsin mediated signaling pathway
GO:0022400 regulation of rhodopsin mediated signaling pathway
GO:0051219 phosphoprotein binding

Subcellular Location

Show/Hide Table
Subcellular Location
Cell projection
Membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR000698 ArrestinFamilyFamily
IPR011021 Arrestin-like, N-terminalDomainDomain
IPR011022 Arrestin C-terminal-like domainDomainDomain
IPR014752 Arrestin-like, C-terminalFamilyHomologous superfamily
IPR014753 Arrestin, N-terminalFamilyHomologous superfamily
IPR014756 Immunoglobulin E-setFamilyHomologous superfamily
IPR017864 Arrestin, conserved siteSiteConserved site

Diseases

Show/Hide Table
Disease IDSourceNameDescription
258100 OMIMNight blindness, congenital stationary, Oguchi type 1 (CSNBO1)A non-progressive retinal disorder characterized by impaired night vision, often associated with nystagmus and myopia. Congenital stationary night blindness Oguchi type is an autosomal recessive form associated with fundus discoloration and abnormally slow dark adaptation. The disease is caused by variants affecting the gene represented in this entry.
613758 OMIMRetinitis pigmentosa 47 (RP47)A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. The disease is caused by variants affecting the gene represented in this entry.

Interactions

5 interactions